CSI Market
Sign In | Register

Core Laboratories Inc (CLB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CLB Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Core Laboratories Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income5.05
Depreciation & amortization7.59
Amortization of Other Assets0.35
Increase (Decrease) in Insurance Assets1.28
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.09
Inventories Decrease /-Increase4.33
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business1.22
Share-based Compensation0.14
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions0.00
Gains (Losses) on Extinguishment of Debt-0.60
Net Recovery Provision for Doubtful Accounts-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Impairments Inventory Write Down And Other Charges-0.84
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-4.62
Increase (Decrease) in Accounts Payable3.26
Accrued Expense-8.42
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.91
Other Working Capital0.00
Other Noncash Income (Expense)0.11
Other net-0.12
Payments for (Proceeds from) Other Operating Activities1.21
Discontinued operations0.00
Net Cash flow from Operating Activities11.77
Investing Activities
Capital Expenditures-8.14
Sale of Capital Items3.07
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Escrow Deposit Disbursements Related To Property Acquisition0.01
Escrow Deposit Disbursements Related To Property Acquisition-
Payments Proceeds From Patents And Other Intangibles-
Proceeds From Sale Of Discontinued Operations-
Proceeds From Non Life Insurance Policies-
Premiums On Life Insurance Policies-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Insurance Settlement, Investing Activities0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets0.00
Accounts payable0.00
Receivables0.00
Proceeds from Life Insurance Policies0.00
Other Net-2.26
Discontinued operations0.00
Net Cash Flow from Investing Activities-7.32
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings81.00
Long-term debt - repayments-77.63
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-6.69
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.19
Other net0.00
Settlement Of Warrants-
Proceeds From Sale Of Note Hedge Claim-
Stock Issued During Period Value New Issues-
Payments of Ordinary Dividends, Noncontrolling Interest0.00
Dividends paid-0.92
Net Cash Flow from Financing Activities-4.42
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow6.71
Total Cash Flow0.03
4 historic quarters locked

Sign in to unlock the full Core Laboratories Inc cash flow history.

Sign In Create Free Account

About Core Laboratories Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: clb-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-326345

Figures are derived from filed reports and may be restated. Historical data is subject to revision.